D1/3-Mage-3-His fusion protein
Term · Oncology and biomedicine · MLC-T-ONC-012889
A recombinant, chimeric protein derived from a melanoma antigenic epitope (MAGE-3) and recognized by specific cytotoxic T lymphocytes. MAGE-3, a human peptide epitope present in the cytosol of melanoma cells, may be expressed as the fusion protein D1/3-Mage-3; this fusion protein may boost antitumoral immune responses when used in a vaccine formulation.
| Identifier | MLC-T-ONC-012889 |
|---|---|
| Field | Oncology and biomedicine |
| Abbreviation | D1/3 MAGE3 HIS |
| Synonyms | D1/3-Mage-3-His fusion protein (SB MAGE-3) |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-012889",
"term": "D1/3-Mage-3-His fusion protein",
"field": "Oncology and biomedicine",
"term_source": "D1/3-Mage-3-His Fusion Protein",
"definition": "A recombinant, chimeric protein derived from a melanoma antigenic epitope (MAGE-3) and recognized by specific cytotoxic T lymphocytes. MAGE-3, a human peptide epitope present in the cytosol of melanoma cells, may be expressed as the fusion protein D1/3-Mage-3; this fusion protein may boost antitumoral immune responses when used in a vaccine formulation.",
"abbreviation": "D1/3 MAGE3 HIS",
"synonyms": [
"D1/3-Mage-3-His fusion protein (SB MAGE-3)"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/d1-3-mage-3-his-fusion-protein/"
}
Record 5,637 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.